Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy

Oncotarget | https://doi.org/10.18632/oncotarget.18200 Steffen Dietz, Holger Sültmann, YueJun Du, Eva Reisinger, Anja Lisa Riediger, Anna-Lena Volckmar, Albrecht Stenzinger, Matthias Schlesner, Dirk Jäger, Markus...

Saved in:
Bibliographic Details
Main Authors: Dietz, Steffen (Author) , Sültmann, Holger (Author) , Du, YueJun (Author) , Riediger, Anja Lisa (Author) , Volckmar, Anna-Lena (Author) , Stenzinger, Albrecht (Author) , Schlesner, Matthias (Author) , Jäger, Dirk (Author) , Hohenfellner, Markus (Author) , Duensing, Stefan (Author) , Grüllich, Carsten (Author) , Pahernik, Sascha (Author)
Format: Article (Journal)
Language:English
Published: May 23, 2017
In: OncoTarget
Year: 2017, Volume: 8, Issue: 43, Pages: 74049-74057
ISSN:1949-2553
DOI:10.18632/oncotarget.18200
Online Access:Verlag, Volltext: http://dx.doi.org/10.18632/oncotarget.18200
Verlag, Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=18200&path[]=58349
Get full text
Author Notes:Steffen Dietz, Holger Sültmann, YueJun Du, Eva Reisinger, Anja Lisa Riediger, Anna-Lena Volckmar, Albrecht Stenzinger, Matthias Schlesner, Dirk Jäger, Markus Hohenfellner, Stefan Duensing, Carsten Grüllich and Sascha Pahernik

MARC

LEADER 00000caa a2200000 c 4500
001 1583839453
003 DE-627
005 20220815060525.0
007 cr uuu---uuuuu
008 181119s2017 xx |||||o 00| ||eng c
024 7 |a 10.18632/oncotarget.18200  |2 doi 
035 |a (DE-627)1583839453 
035 |a (DE-576)513839453 
035 |a (DE-599)BSZ513839453 
035 |a (OCoLC)1341022654 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dietz, Steffen  |d 1988-  |e VerfasserIn  |0 (DE-588)1148996575  |0 (DE-627)1009298062  |0 (DE-576)496511556  |4 aut 
245 1 0 |a Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy  |c Steffen Dietz, Holger Sültmann, YueJun Du, Eva Reisinger, Anja Lisa Riediger, Anna-Lena Volckmar, Albrecht Stenzinger, Matthias Schlesner, Dirk Jäger, Markus Hohenfellner, Stefan Duensing, Carsten Grüllich and Sascha Pahernik 
264 1 |c May 23, 2017 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 19.11.2018 
520 |a Oncotarget | https://doi.org/10.18632/oncotarget.18200 Steffen Dietz, Holger Sültmann, YueJun Du, Eva Reisinger, Anja Lisa Riediger, Anna-Lena Volckmar, Albrecht Stenzinger, Matthias Schlesner, Dirk Jäger, Markus... 
700 1 |a Sültmann, Holger  |d 1962-  |e VerfasserIn  |0 (DE-588)172777291  |0 (DE-627)697708144  |0 (DE-576)133633926  |4 aut 
700 1 |a Du, YueJun  |d 1975-  |e VerfasserIn  |0 (DE-588)1139669559  |0 (DE-627)897393511  |0 (DE-576)493383727  |4 aut 
700 1 |a Riediger, Anja Lisa  |e VerfasserIn  |0 (DE-588)1148996451  |0 (DE-627)1009297805  |0 (DE-576)496511262  |4 aut 
700 1 |a Volckmar, Anna-Lena  |d 1984-  |e VerfasserIn  |0 (DE-588)173874916  |0 (DE-627)698776666  |0 (DE-576)134713478  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Schlesner, Matthias  |d 1978-  |e VerfasserIn  |0 (DE-588)138455201  |0 (DE-627)602593867  |0 (DE-576)307654656  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
700 1 |a Duensing, Stefan  |d 1967-  |e VerfasserIn  |0 (DE-588)1074044487  |0 (DE-627)830213007  |0 (DE-576)435550098  |4 aut 
700 1 |a Grüllich, Carsten  |d 1965-  |e VerfasserIn  |0 (DE-588)14101914X  |0 (DE-627)624500985  |0 (DE-576)321797981  |4 aut 
700 1 |a Pahernik, Sascha  |d 1968-  |e VerfasserIn  |0 (DE-588)122063163  |0 (DE-627)081713495  |0 (DE-576)293073147  |4 aut 
773 0 8 |i Enthalten in  |t OncoTarget  |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010  |g 8(2017), 43, Seite 74049-74057  |h Online-Ressource  |w (DE-627)63035975X  |w (DE-600)2560162-3  |w (DE-576)325343764  |x 1949-2553  |7 nnas  |a Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy 
773 1 8 |g volume:8  |g year:2017  |g number:43  |g pages:74049-74057  |g extent:9  |a Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy 
856 4 0 |u http://dx.doi.org/10.18632/oncotarget.18200  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=18200&path[]=58349  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181119 
993 |a Article 
994 |a 2017 
998 |g 138455201  |a Schlesner, Matthias  |m 138455201:Schlesner, Matthias  |d 140000  |e 140000PS138455201  |k 0/140000/  |p 8 
998 |g 122063163  |a Pahernik, Sascha  |m 122063163:Pahernik, Sascha  |d 50000  |e 50000PP122063163  |k 0/50000/  |p 13  |y j 
998 |g 14101914X  |a Grüllich, Carsten  |m 14101914X:Grüllich, Carsten  |d 910000  |e 910000PG14101914X  |k 0/910000/  |p 12 
998 |g 1074044487  |a Duensing, Stefan  |m 1074044487:Duensing, Stefan  |d 910000  |d 910200  |e 910000PD1074044487  |e 910200PD1074044487  |k 0/910000/  |k 1/910000/910200/  |p 11 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |e 910000PH133862518  |e 910200PH133862518  |k 0/910000/  |k 1/910000/910200/  |p 10 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 9 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 7 
998 |g 173874916  |a Volckmar, Anna-Lena  |m 173874916:Volckmar, Anna-Lena  |d 910000  |d 912000  |e 910000PV173874916  |e 912000PV173874916  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 1148996451  |a Riediger, Anja Lisa  |m 1148996451:Riediger, Anja Lisa  |d 50000  |e 50000PR1148996451  |k 0/50000/ 
998 |g 1139669559  |a Du, YueJun  |m 1139669559:Du, YueJun  |d 910000  |d 910200  |e 910000PD1139669559  |e 910200PD1139669559  |k 0/910000/  |k 1/910000/910200/ 
998 |g 172777291  |a Sültmann, Holger  |m 172777291:Sültmann, Holger  |d 50000  |e 50000PS172777291  |k 0/50000/ 
998 |g 1148996575  |a Dietz, Steffen  |m 1148996575:Dietz, Steffen  |d 910000  |e 910000PD1148996575  |k 0/910000/  |p 1  |x j 
999 |a KXP-PPN1583839453  |e 3032688329 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy","title":"Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy"}],"physDesc":[{"extent":"9 S."}],"note":["Gesehen am 19.11.2018"],"name":{"displayForm":["Steffen Dietz, Holger Sültmann, YueJun Du, Eva Reisinger, Anja Lisa Riediger, Anna-Lena Volckmar, Albrecht Stenzinger, Matthias Schlesner, Dirk Jäger, Markus Hohenfellner, Stefan Duensing, Carsten Grüllich and Sascha Pahernik"]},"person":[{"given":"Steffen","family":"Dietz","display":"Dietz, Steffen","role":"aut"},{"family":"Sültmann","display":"Sültmann, Holger","role":"aut","given":"Holger"},{"given":"YueJun","display":"Du, YueJun","family":"Du","role":"aut"},{"display":"Riediger, Anja Lisa","family":"Riediger","role":"aut","given":"Anja Lisa"},{"given":"Anna-Lena","role":"aut","family":"Volckmar","display":"Volckmar, Anna-Lena"},{"given":"Albrecht","display":"Stenzinger, Albrecht","family":"Stenzinger","role":"aut"},{"role":"aut","family":"Schlesner","display":"Schlesner, Matthias","given":"Matthias"},{"given":"Dirk","role":"aut","family":"Jäger","display":"Jäger, Dirk"},{"given":"Markus","role":"aut","family":"Hohenfellner","display":"Hohenfellner, Markus"},{"display":"Duensing, Stefan","family":"Duensing","role":"aut","given":"Stefan"},{"display":"Grüllich, Carsten","family":"Grüllich","role":"aut","given":"Carsten"},{"given":"Sascha","role":"aut","display":"Pahernik, Sascha","family":"Pahernik"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"pubHistory":["1.2010,Mai -"],"disp":"Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapyOncoTarget","part":{"volume":"8","pages":"74049-74057","text":"8(2017), 43, Seite 74049-74057","extent":"9","issue":"43","year":"2017"},"recId":"63035975X","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"title":[{"title":"OncoTarget","subtitle":"open access impact journal","title_sort":"OncoTarget"}],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 16.08.2018"],"id":{"issn":["1949-2553"],"zdb":["2560162-3"],"eki":["63035975X"]},"origin":[{"publisher":"Impact Journals LLC","dateIssuedDisp":"2010-","dateIssuedKey":"2010","publisherPlace":"[Erscheinungsort nicht ermittelbar]"}]}],"origin":[{"dateIssuedDisp":"May 23, 2017","dateIssuedKey":"2017"}],"id":{"doi":["10.18632/oncotarget.18200"],"eki":["1583839453"]},"recId":"1583839453"} 
SRT |a DIETZSTEFFPATIENTSPE2320